NaturalNews)

Reflecting on the undue influence that drug giant GlaxoSmithKline appears to have exhibited over the FDA's decision-making process regarding the diabetes blockbuster Avandia, Time magazine author Massimo Calabresi asks, "Does the FDA have a drug problem?"

The saga over Avandia has embarrassed the FDA and further tarnished the reputation of the already embattled pharmaceutical industry. As early as the late '90s, researchers were already sounding alarms over the drug.

"In April of 1999, FDA medical reviewer Robert I. Misbin reported to his FDA supervisors that a GlaxoSmithKline drug for Type 2 diabetes then under review, Avandia (rosiglitazone), appeared to increase the incidence of congestive heart failure in study participants," writes Jonathan W. Emord in his book The Rise of Tyranny

Learn more: http://www.naturalnews.com/030735_TIME_Magazine_FDA.html#ixzz18DuZVpJh